Long-term mucosal healing, clinical response and clinical remission in patients with ulcerative colitis treated with the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody ontamalimab (SHP647): results from the open-label extension study TURANDOT II

Silvio Danese  1     William Sandborn  2     Walter Reinisch  3     Xavier Hebuterne  4     Maria Kłopocka  5     Dino Tarabar  6     Tomáš Vaňásek     Miloš Greguš     Paul A Hellstern     Joo Sung Kim     Miles P. Sparrow     Kenneth Gorelick     Martina Goetsch     Caleb Bliss     Charu Gupta     Fabio Cataldi     Severine Vermeire    
1 Humanitas University,Milan,Italy
2 University of California San Diego,La Jolla,United States
3 Medical University of Vienna,Vienna,Austria
4 University of Nice Sophia-Antipolis, CHU of Nice,Nice,France
5 Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz,Bydgoszcz,Poland
6 Clinic of Gastroenterology and Hepatology, Military Med

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing